During the past decade, Ahmed Talaat Ahmed conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Ahmed Talaat Ahmed" are "Cesarean Section" (1 trials), "Hypotension" (1 trials), "Renal Injury" (1 trials) and "Spinal Shock" (1 trials). Many other conditions were trialed in "Ahmed Talaat Ahmed" in a lesser frequency.

Most popular intervention types in "Ahmed Talaat Ahmed" are "Drug" (3 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bupivacaine" (1 trials), "Dexmedetomidine" (1 trials), "Magnesium Sulfate" (1 trials), "Midodrine Oral Tablet" (1 trials) and "Minirin oral tablet" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ahmed Talaat Ahmed" are 2 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Ahmed Talaat Ahmed". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Ahmed Talaat Ahmed, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ahmed Talaat Ahmed, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".